Abstract
Atrial fibrillation (AF) is the most common sustained arrhythmia associated with significant morbidity and mortality. The mechanisms underlying the pathogenesis of AF are poorly understood, although electrophysiological remodeling has been described as an important initiating step. There is growing evidence that oxidative stress is involved in the pathogenesis of AF. Many known triggers of oxidative stress, such as age, diabetes, smoking, and inflammation, are linked with an increased risk of arrhythmia. Numerous preclinical studies and clinical trials reported the importance of antioxidant therapy in the prevention of AF, using vitamins C and E, polyunsaturated fatty acids, statins, or nitric oxide donors. The aim of our work is to give a current overview and analysis of opportunities, challenges, and benefits of antioxidant therapy in AF.
Similar content being viewed by others
References
Akar FG, Aon MA, Tomaselli GF, O’Rourke B (2005) The mitochondrial origin of postischemic arrhythmias. J Clin Invest 115:3527–3535
Allessie M, Ausma J, Schotten U (2002) Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 54:230–246
Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG, Tarazi R, Shroyer AL, Sethi GK, Grover FL, Hammermeister KE (1997) Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg 226:501–513
Amar D, Zhang H, Heerdt PM, Park B, Fleisher M, Thaler HT (2005) Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest 128:3421–3427
Argmann CA, Edwards JY, Sawyez CG, O’Neil CH, Hegele RA, Pickering JG, Huff MW (2005) Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux. J Biol Chem 280:22212–22221
Arumanayagam M, Chan S, Tong S, Sanderson JE (2001) Antioxidant properties of carvedilol and metoprolol in heart failure: a double-blind randomized controlled trial. J Cardiovasc Pharmacol 37:48–54
Babior BM, Lambeth JD, Nauseef W (2002) The neutrophil NADPH oxidase. Arch Biochem Biophys 397:342–344
Bähring R, Milligan CJ, Vardanyan V, Engeland B, Young BA, Dannenberg J, Waldschutz R, Edwards JP, Wray D, Pongs O (2001) Coupling of voltage-dependent potassium channel inactivation and oxidoreductase active site of Kvbeta subunits. J Biol Chem 276:22923–22929
Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O’Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, Hare JM (2002) Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416:337–339
Barrett DM, Black SM, Todor H, Schmidt-Ullrich RK, Dawson KS, Mikkelsen RB (2005) Inhibition of protein-tyrosine phosphatases by mild oxidative stresses is dependent on S-nitrosylation. J Biol Chem 280:14453–14461
Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952
Bolesta S, Aungst TD, Kong F (2012) Effect of sodium nitroprusside on the occurrence of atrial fibrillation after cardiothoracic surgery. Ann Pharmacother 46:785–792
Bolesta S, Kong F (2015) Effect of statins on the incidence of postoperative atrial fibrillation after cardiac valve surgery. Pharmacotherapy 35:998–1006
Bonilla IM, Sridhar A, Györke S, Cardounel AJ, Carnes CA (2012) Nitric oxide synthases and atrial fibrillation. Front Physiol 3:105
Boos CJ, Anderson RA, Lip GY (2006) Is atrial fibrillation an inflammatory disorder? Eur Heart J 27:136–149
Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kühlkamp V (1999) Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 44:121–131
Brundel BJ, Henning RH, Ke L, van Gelder IC, Crijns HJ, Kampinga HH (2006a) Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation. J Mol Cell Cardiol 41:555–562
Brundel BJ, Shiroshita-Takeshita A, Qi X, Yeh YH, Chartier D, van Gelder IC, Henning RH, Kampinga HH, Nattel S (2006b) Induction of heat shock response protects the heart against atrial fibrillation. Circ Res 99:1394–1402
Brunetti-Pierri N, Ng P (2008) Progress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors. Gene Ther 15:553–560
Bukowska A, Hammwöhner M, Sixdorf A, Schild L, Wiswedel I, Röhl FW, Wolke C, Lendeckel U, Aderkast C, Bochmann S, Chilukoti RK, Mostertz J, Bramlage P, Goette A (2012) Dronedarone prevents microcirculatory abnormalities in the left ventricle during atrial tachypacing in pigs. Br J Pharmacol 166:964–980
Bukowska A, Schild L, Keilhoff G, Hirte D, Neumann M, Gardemann A, Neumann KH, Röhl FW, Huth C, Goette A, Lendeckel U (2008) Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia. Exp Biol Med 233:558–574
Cai H, Li Z, Goette A, Mera F, Honeycutt C, Feterik K, Wilcox JN, Dudley SC Jr, Harrison DG, Langberg JJ (2002) Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation 106:2854–2858
Calò L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E, Meo A, Pandozi C, Staibano M, Santini M (2005) N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 45:1723–1728
Camici PG, Crea F (2007) Coronary microvascular dysfunction. N Engl J Med 356:830–840
Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S, Kanderian A, Pavia S, Hamlin RL, McCarthy PM, Bauer JA, Van Wagoner DR (2001) Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 89:32–38
Carnes CA, Janssen PM, Ruehr ML, Nakayama H, Nakayama T, Haase H, Bauer JA, Chung MK, Fearon IM, Gillinov AM, Hamlin RL, Van Wagoner DR (2007) Atrial glutathione content, calcium current and contractility. J Biol Chem 282:28063–28073
Castillo R, Rodrigo R, Perez F, Cereceda M, Asenjo R, Zamorano J, Navarrete R, Villalabeitia E, Sanz J, Baeza C, Aguayo R (2011) Antioxidant therapy reduces oxidative and inflammatory tissue damage in patients subjected to cardiac surgery with extracorporeal circulation. Basic Clin Pharmacol Toxicol 108:256–262
Cavolli R, Kaya K, Aslan A, Emiroglu O, Erturk S, Korkmaz O, Oguz M, Tasoz R, Ozyurda U (2008) Does sodium nitroprusside decrease the incidence of atrial fibrillation after myocardial revascularization? A pilot study. Circulation 118:476–481
Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, Chau LY (2002) Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111:–8
Cheng J, Niwa R, Kamiya K, Toyama J, Kodama I (1999) Carvedilol blocks the repolarizing K+ currents and the L-type Ca2+ current in rabbit ventricular myocytes. Eur J Pharmacol 376:189–201
Christ T, Boknik P, Wöhrl S, Wettwer E, Graf EM, Bosch RF, Knaut M, Schmitz W, Ravens U, Dobrev D (2004) L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 110:2651–2657
Chu Y, Alwahdani A, Iida S, Lund DD, Faraci FM, Heistad DD (2005) Vascular effects of the human extracellular superoxide dismutase R213G variant. Circulation 112:1047–1053
Cockrell AS, Kafri T (2007) Gene delivery by lentivirus vectors. Mol Biotechnol 36:184–204
Dehghani MR, Kasianzadeh M, Rezaei Y, Sepehrvand N (2015) Atorvastatin reduces the incidence of postoperative atrial fibrillation in statin-naive patients undergoing isolated heart valve surgery: a double-blind, placebo-controlled randomized trial. J Cardiovasc Pharmacol Ther 20:465–472
Dixon LJ, Hughes SM, Rooney K, Madden A, Devine A, Leahey W, Henry W, Johnston GD, McVeigh GE (2005) Increased superoxide production in hypertensive patients with diabetes mellitus: role of nitric oxide synthase. Am J Hypertens 18:839–843
Doughan AK, Harrison DG, Dikalov SI (2008) Molecular mechanisms of angiotensin II mediated mitochondrial dysfunction. Linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 102:488–496
Echahidi N, Pibarot P, O’Hara G, Mathieu P (2008) Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 51:793–801
Ellenbogen KA, Chung MK, Asher CR, Wood MA (1997) Postoperative atrial fibrillation. Adv Card Surg 9:109–130
Farquharson AL, Metcalf RG, Sanders P, Stuklis R, Edwards JR, Gibson RA, Cleland LG, Sullivan TR, James MJ, Young GD (2011) Effect of dietary fish oil on atrial fibrillation after cardiac surgery. Am J Cardiol 108:851–856
Fearon IM, Brown ST (2004) Acute and chronic hypoxic regulation of recombinant hNa(v)1.5 alpha subunits. Biochem Biophys Res Commun 324:1289–1295
Fearon IM, Palmer AC, Balmforth AJ, Ball SG, Varadi G, Peers C (2000) Hypoxic and redox inhibition of the human cardiac L-type Ca2+ channel. Adv Exp Med Biol 475:209–218
Feuerstein G, Yue TL, Ma X, Ruffolo RR (1998) Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol. Prog Cardiovasc Dis 41:17–24
Galaris D, Korantzopoulos P (1997) On the molecular mechanism of metmyoglobin-catalyzed reduction of hydrogen peroxide by ascorbate. Free Radic Biol Med 22:657–667
Gautier M, Zhang H, Fearon IM (2007) Peroxynitrite formation mediates LPC-induced augmentation of cardiac late sodium currents. J Mol Cell Cardiol 44:241–251
Goette A, Honeycutt C, Langberg JJ (1996) Electrical remodeling in atrial fibrillation: time course and mechanisms. Circulation 94:2968–2974
Hanna IR, Heeke B, Bush H, Brosius L, King-Hageman D, Dudley SC Jr, Beshai JF, Langberg JJ (2006) Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. Heart Rhythm 3:881–886
Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, Stijnen T, Lip GY, Witteman JC (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27:949–953
Heidarsdottir R, Arnar DO, Skuladottir GV, Torfason B, Edvardsson V, Gottskalksson G, Palsson R, Indridason OS (2010) Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? Europace 12:356–363
Heller R, Werner-Felmayer G, Werner ER (2006) Antioxidants and endothelial nitric oxide synthesis. Eur J Clin Pharmacol 62:21–28
Hidalgo C, Donoso P, Carrasco MA (2005) The ryanodine receptors Ca2+ release channels: cellular redox sensors? IUBMB Life 57:315–322
Hoehn B, Yenari MA, Sapolsky RM, Steinberg GK (2003) Glutathione peroxidase overexpression inhibits cytochrome C release and proapoptotic mediators to protect neurons from experimental stroke. Stroke 34:2489–2494
Huang CX, Liu Y, Xia WF, Tang YH, Huang H (2009) Oxidative stress: a possible pathogenesis of atrial fibrillation. Med Hypotheses 72:466–467
Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, Aizawa T, Ishizaka N, Nagai R (2002) Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 22:1680–1685
Kannel WB, Wolf PA, Benjamin EJ, Levy D (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2–9
Kim YM, Guzik TJ, Zhang YH, Zhang MH, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casadei B (2005) A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 97:629–636
Kirsch M, Groot DM (2000) Ascorbate is a potent antioxidant against peroxynitrite-induced oxidation reactions. Evidence that ascoarbate acts by re-reducing substrate radicals produced by peroxynitrite. J Biol Chem 275:16702–16708
Kochiadakis GE, Skalidis EI, Kalebubas MD, Igoumenidis NE, Chrysostomakis SI, Kanoupakis EM, Simantirakis EN, Vardas PE (2002) Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans. Eur Heart J 23:734–741
Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA (2007) The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 115:135–143
Korantzopoulos P, Kolettis TM, Kountouris E, Dimitroula V, Karanikis P, Pappa E, Siogas K, Goudevenos JA (2005) Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol 102:321–326
Kubatka P, Bojková B, Kassayová M, Orendáš P, Kajo K, Výbohová D, Kružliak P, Adamicová K, Péč M, Stollárová N, Adamkov M (2014) Combination of pitavastatin and melatonin shows partial antineoplastic effects in a rat breast carcinoma model. Acta Histochem 116:1454–1461
Kubatka P, Kajo K, Zihlavnikova K, Adamicova K, Vybohova D, Pec M, Nosal V, Stollarova N, Bojkova B, Kassayova M, Orendas P (2012) Immunohistochemical and histomorphological analysis of rat mammary tumors after simvastatin treatment. Neoplasma 59:516–523
Kubatka P, Stollárová N, Škarda J, Žihlavníková K, Kajo K, Kapinová A, Adamicová K, Péč M, Dobrota D, Bojková B, Kassayová M, Orendáš P (2013) Preventive effects of fluvastatin in rat mammary carcinogenesis. Eur J Cancer Prev 22:352–357
Kumagai K, Nakashima H, Saku K (2004) The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 62:105–111
Lassnigg A, Punz A, Barker R, Keznickl P, Manhart N, Roth E, Hiesmayr M (2003) Influence of intravenous vitamin E supplementation in cardiac surgery on oxidative stress: a double-blinded, randomized, controlled study. Br J Anaesth 90:148–154
Lip GY, Kakar P, Watson T (2007) Atrial fibrillation—the growing epidemic. Heart 93:542–543
Liu T, Li GP (2006) Statins may prevent postoperative atrial fibrillation through autonomic modulation. Am J Cardiol 97:1266
Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D’Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ (2004) Lifetime risk for development of atrial fibrillation: the Framingham Heart study. Circulation 110:1042–1046
Luoma JS, Strålin P, Marklund SL, Hiltunen TP, Särkioja T, Ylä-Herttuala S (1998) Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol 18:157–167
Lupo E, Locher R, Weisser B, Vetter W (1994) In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alphatocopherol. Biochem Biophys Res Commun 203:1803–1808
Maack C, Cortassa S, Aon MA, Ganesan AN, Liu T, O’Rourke B (2006) Elevated cytosolic Na+ decreases mitochondrial Ca2+ uptake during excitation-contraction coupling and impairs energetic adaptation in cardiac myocytes. Circ Res 99:172–182
Marín F, Pascual DA, Roldán V, Arribas JM, Ahumada M, Tornel PL, Oliver C, Gómez-Plana J, Lip GY, Valdés M (2006) Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol 97:55–60
Mason RP, Marche P, Hintze TH (2003) Novel vascular biology of thirdgeneration L-type calcium channel antagonists: ancillary actions of amlodipine. Atherosc Thromb Vasc Biol 23:2155–2163
Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JA (2001) Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104:174–180
Milei J, Forcada P, Fraga CG, Grana DR, Iannelli G, Chiariello M, Tritto I, Ambrosio G (2007) Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion. Cardiovas Res 73:710–719
Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS (2006) Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114:119–125
Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD, Beilin LJ (2003) Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated hypertensive type 2 diabetic subjects. Free Radic Biol Med 35:772–781
Morillo CA, Klein GJ, Jones DL, Guiraudon CM (1995) Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 91:1588–1595
Murdoch CE, Grieve DJ, Cave AC et al (2006) NADPH oxidase and heart failure. Curr Opin Pharmacol 6:148–153
Ooie T, Takahashi N, Saikawa T, Nawata T, Arikawa M, Yamanaka K, Hara M, Shimada T, Sakata T (2001) Single oral dose of geranylgeranylacetone induces heat-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart. Circulation 104:1837–1843
Orendáš P, Kubatka P, Bojková B, Kassayová M, Kajo K, Výbohová D, Kružliak P, Péč M, Adamkov M, Kapinová A, Adamicová K, Sadloňová V, Chmelová M, Stollárová N (2014) Melatonin potentiates the anti-tumour effect of pravastatin in rat mammary gland carcinoma model. Int J Exp Pathol 95:401–410
Otterbein LE, Soares MP, Yamashita K, Bach FH (2003) Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24:449–455
Ozaydin M, Peker O, Erdogan D, Kapan S, Turker Y, Varol E, Ozguner F, Dogan A, Ibrisim E (2008) N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. Eur Heart J 29:625–631
Patti G, Chello M, Candura D, Pasceri V, D’Ambrosio A, Covino E, Di Sciascio G (2006) Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (atorvastatin for reduction of myocardial dysrhythmia after cardiac surgery) study. Circulation 114:1455–1461
Pierri MD, Crescenzi G, Zingaro C, D’Alfonso A, Capestro F, Scocco V, Brugia M, Torracca L (2016) Prevention of atrial fibrillation and inflammatory response after on-pump coronary artery bypass using different statin dosages: a randomized, controlled trial. Gen Thorac Cardiovasc Surg 64:395–402
Planavila A, Laguna JC, Vazquez-Carrera M (2005) Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation. Biochim Biophys Acta 1687:76–83
Range FT, Schäfers M, Acil T, Schäfers KP, Kies P, Paul M, Hermann S, Brisse B, Breithardt G, Schober O, Wichter T (2007) Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation. Eur Heart J 28:2223–2230
Rezaei Y, Gholami-Fesharaki M, Dehghani MR, Arya A, Haghjoo M, Arjmand N (2016a) Statin antiarrhythmic effect on atrial fibrillation in statin-naive patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol Ther 21:167–176
Rezaei Y, Samiei N, Hosseini S (2016b) Do statins attenuate postoperative atrial fibrillation in isolated heart valve surgery? Pharmacotherapy 36:e16–e17
Rodrigo R, Vinay J, Castillo R, Cereceda M, Asenjo R, Zamorano J, Araya J, Castillo-Koch R, Espinoza J, Larraín E (2010) Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial fibrillation. Int J Cardiol 138:221–228
Saravanan P, Bridgewater B, West AL, O’Neill SC, Calder PC, Davidson NC (2010) Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol 3:46–53
Sasaki N, Sato T, Marbán E, O’Rourke B (2001) ATP consumption by uncoupled mitochondria activates sarcolemmal K(ATP) channels in cardiac myocytes. Am J Physiol Heart Circ Physiol 280:H1882–H1888
Savelieva I, Kourliouros A, Camm J (2010) Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance. Naunyn Schmiedeberg’s Arch Pharmacol 381:207–219
Schillinger M, Exner M, Minar E, Mlekusch W, Müllner M, Mannhalter C, Bach FH, Wagner O (2004) Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. J Am Coll Cardiol 43:950–957
Seitelberger R, Hannes W, Gleichauf M, Keilich M, Christoph M, Fasol R (1994) Effects of diltiazem on perioperative ischemia, arrhythmias, and myocardial function in patients undergoing elective coronary bypass grafting. J Thor Cardiovasc Surg 107:811–821
Shiroshita-Takeshita A, Schram G, Lavoie J, Nattel S (2004) Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation 110:2313–2319
Sisto T, Paajanen H, Metsä-Ketelä T, Harmoinen A, Nordback I, Tarkka M (1995) Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. Ann Thor Sur 59:1519–1523
Skasa M, Jüngling E, Picht E, Schöndube F, Lückhoff A (2001) L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation. Basic Res Cardiol 96:151–159
Song HJ, Lee TS, Jeong JH, Min YS, Shin CY, Sohn UD (2005) Hydrogen peroxide-induced extracellular signal-regulated kinase activation in cultured feline ileal smooth muscle cells. J Pharmacol Exp Ther 312:391–398
Sorescu D, Szöcs K, Griendling KK (2001) NAD(P)H oxidases and their relevance to atherosclerosis. Trends Cardiovasc Med 11:124–131
Sorescu D, Weiss D, Lassègue B, Clempus RE, Szöcs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK (2002) Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105:1429–1435
Sorice M, Tritto FP, Sordelli C, Gregorio R, Piazza L (2011) N-3 polyunsaturated fatty acids reduce post-operative atrial fibrillation incidence in patients undergoing “on-pump” coronary artery bypass graft surgery. Monaldi Arch Chest Dis 76:93–98
Stocker R, Perrella MA (2006) Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation 114:2178–2189
Sugawara H, Tobise K, Kikuchi K (1996) Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation. Hypertens Res 19:223–228
Sugiyama M, Ohashi M, Takase H, Sato K, Ueda R, Dohi Y (2005) Effects of atorvastatin on inflammation and oxidative stress. Heart Vessel 20:133–136
Sun J, Picht E, Ginsburg KS, Bers DM, Steenbergen C, Murphy E (2006) Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury. Circ Res 98:403–411
Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T (1995) Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270:296–299
Tieleman RG, Van Gelder IC, Crijns HJ, De Kam PJ, Van Den Berg MP, Haaksma J, Van Der Woude HJ, Allessie MA (1998) Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 31:167–173
Thiedemann KU, Ferrans VJ (1977) Left atrial ultrastructure in mitral valvular disease. Am J Pathol 89:575–604
Van Wagoner DR (2003) Electrophysiological remodeling in human atrial fibrillation. Pacing Clin Electrophysiol 26:1572–1575
Van Wagoner DR, Pond AL, Lamorgese M, Rossie SS, McCarthy PM, Nerbonne JM (1999) L-type Ca2+ currents and human atrial fibrillation. Circ Res 85:428–436
Van Wagoner DR, Pond AL, McCarthy PM, Trimmer JS, Nerbonne JM (1997) Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 80:772–781
Vest JA, Wehrens XH, Reiken SR, Lehnart SE, Dobrev D, Chandra P, Danilo P, Ravens U, Rosen MR, Marks AR (2005) Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 111:2025–2032
Wang X, Takeda S, Mochizuki S, Jindal R, Dhalla NS (1999) Mechanisms of hydrogen peroxide-induced increase in intracellular calcium in cardiomyocytes. J Cardiovasc Pharmacol Ther 4:41–48
Warnholtz A, Nickenig G, Schulz E, Macharzina R, Bräsen JH, Skatchkov M, Heitzer T, Stasch JP, Griendling KK, Harrison DG, Böhm M, Meinertz T, Münzel T (1999) Increased NADHoxidase-mediated superoxide production in the early stages of atherosclerosis:evidence for involvement of the renin-angiotensin system. Circulation 99:2027–2033
Woo YJ, Zhang JC, Vijayasarathy C, Zwacka RM, Englehardt JF, Gardner TJ, Sweeney HL (1998) Recombinant adenovirus-mediated cardiac gene transfer of superoxide dismutase and catalase attenuates postischemic contractile dysfunction. Circulation 98:255–260
Yue TL, McKenna PJ, Gu JL, Cheng HY, Ruffolo RE Jr, Feuerstein GZ (1994) Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils. Cardiovasc Res 28:400–406
Zhang XP, Loke KE, Mital S, Chahwala S, Hintze TH (2002) Paradoxical release of nitric oxide by an L-type calcium channel antagonist, the R+ enantiomer of amlodipine. J Cardiovasc Pharmacol 39:208–214
Zhu HL, Stewart AS, Taylor MD, Vijayasarathy C, Gardner TJ, Sweeney HL (2000) Blocking free radical production via adenoviral gene transfer decreases cardiac ischemia-reperfusion injury. Mol Ther 2:470–475
Rozmaritsa N, Christ T, Van Wagoner DR, Haase H, Stasch JP, Matschke K, Ravens U (2014) Attenuated response of L-type calcium current to nitric oxide in atrial fibrillation. Cardiovasc Res 101:533–542
Simon JN, Duglan D, Casadei B, Carnicer R (2014) Nitric oxide synthase regulation of cardiac excitation-contraction coupling in health and disease. J Mol Cell Cardiol 73:80–91
Farraha M, Chong JJ, Kizana E (2016) Therapeutic prospects of gene therapy for atrial fibrillation. Heart Lung Circ 25:808–813
Kirstein M, Rivet-Bastide M, Hatem S, Benardeau A, Mercadier JJ, Fischmeister R (1995) Nitric oxide regulates the calcium current in isolated human atrial myocytes. J Clin Invest 95:794–802
Gonzalez DR, Treuer A, Sun QA, Stamler JS, Hare JM (2009) S-nitrosylation of cardiac ion channels. J Cardiovasc Pharmacol 54:188–195
Tamargo J, Caballero R, Gómez R, Delpón E (2010) Cardiac electrophysiological effects of nitric oxide. Cardiovasc Res 87:593–600
Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ (2014) Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 129:837–847
Qi XY, Yeh YH, Xiao L, Burstein B, Maguy A, Chartier D, Villeneuve LR, Brundel BJ, Dobrev D, Nattel S (2008) Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current. Circ Res 103:845–854
Lu Y, Zhang Y, Wang N, Pan Z, Gao X, Zhang F, Zhang Y, Shan H, Luo X, Bai Y, Sun L, Song W, Xu C, Wang Z, Yang B (2010) MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation 122:2378–2387
Harada M, Tadevosyan A, Qi X, Xiao J, Liu T, Voigt N, Karck M, Kamler M, Kodama I, Murohara T, Dobrev D, Nattel S (2015) Atrial fibrillation activates AMP-dependent protein kinase and its regulation of cellular calcium handling: potential role in metabolic adaptation and prevention of progression. J Am Coll Cardiol 66:47–58
Yeh YH, Kuo CT, Chan TH, Chang GJ, Qi XY, Tsai F, Nattel S, Chen WJ (2011) Transforming growth factor-β and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes. Cardiovasc Res 91:62–70
Yeh YH, Kuo CT, Chang GJ, Qi XY, Nattel S, Chen WJ (2013) Nicotinamide adenine dinucleotide phosphate oxidase 4 mediates the differential responsiveness of atrial versus ventricular fibroblasts to transforming growth factor-β. Circ Arrhythm Electrophysiol 6:790–798
Nattel S, Dobrev D (2012) The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities. Eur Heart J 33:1870–1877
Heijman J, Voigt N, Nattel S, Dobrev D (2014) Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ Res 114:1483–1499
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Gasparova, I., Kubatka, P., Opatrilova, R. et al. Perspectives and challenges of antioxidant therapy for atrial fibrillation. Naunyn-Schmiedeberg's Arch Pharmacol 390, 1–14 (2017). https://doi.org/10.1007/s00210-016-1320-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-016-1320-9